Pleural Diseases: Saline Irrigation in Pleural Infection, Epidemiology of Pneumothorax, and Bevacizumab in Mesothelioma.

about

Pleural Diseases: Saline Irrigation in Pleural Infection, Epidemiology of Pneumothorax, and Bevacizumab in Mesothelioma.

Item

http://www.wikidata.org/entity/Q40166240

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pleural Diseases: Saline Irrig ...... d Bevacizumab in Mesothelioma.

@en

type

Item

label

Pleural Diseases: Saline Irrig ...... d Bevacizumab in Mesothelioma.

@en

prefLabel

Pleural Diseases: Saline Irrig ...... d Bevacizumab in Mesothelioma.

@en

P1476

Pleural Diseases: Saline Irrig ...... d Bevacizumab in Mesothelioma.

@en

P2093

Ioannis Psallidas

http://www.w3.org/2001/XMLSchema#string

John P Corcoran

http://www.w3.org/2001/XMLSchema#string

Najib M Rahman

http://www.w3.org/2001/XMLSchema#string

Robert J Hallifax

http://www.w3.org/2001/XMLSchema#string

P2860

BTS statement on malignant mesothelioma in the UK, 2007.

Atmospheric pressure influences the risk of pneumothorax: beware of the storm!

Smoking and the increased risk of contracting spontaneous pneumothorax.

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974.

U.K. Controlled trial of intrapleural streptokinase for pleural infection.

Epidemiology of pneumothorax in England.

Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma

VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.

Emergence of parapneumonic empyema in the USA.

P304

382-385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201608-1676RR

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

196

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28598211

http://www.w3.org/2001/XMLSchema#string

P921

pneumothorax

bevacizumab

P932

5549865

http://www.w3.org/2001/XMLSchema#string